MarketInOut Stock Screener Log In | Sign Up

Lunai Bioworks Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/29/2026
Lunai Bioworks Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.02 mln
Float4.16 mln
Earnings Date11/13/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

0 / 100
Severely lagging

Pre-Tax Margin

-6,852%
Severely loss-making

ROE

31.55
Very strong

Altman Z-Score

-75.44
Deeply distressed

ROA

-42.76
Deeply negative

Business Description

Lunai Bioworks Inc. is a Los Angeles-based biotechnology company operating in the United States and the Netherlands, focused on developing treatments and diagnostic tools for cancer. The company is working on genetically engineered cell-based vaccines designed to target solid tumors, including pancreatic and breast cancers, alongside an artificial intelligence platform that can detect cancer and its return at an early stage, even before symptoms appear. Formerly known as Renovaro Inc., the company also has a presence in biodefense.

Key Fundamentals

EPS-1.06
ROE31.55
RPS0.01
ROIC-74.24
ROA-42.76
Interest Cover-33.46
EBITDA, mln-3.12
EV / EBITDA-0.29
EV / EBIT-0.28
Revenue, mln0.05
EV / Revenue17.15

Quote Details

Last 0.1648
Change -0.0713 (-30.2%)
Open 0.229
Volume 845,936
Turnover 139,410
Average Volume 484,232

Financial Ratios

Pre-Tax Profit Margin-6,852
Current Ratio0.11
Price / Sales18.04
PEG Ratio0.01

Financial Strength

Altman Z-Score-75.44
Piotroski F-Score 4 / 9
Short Ratio1.31
Short % of Float2.61

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -64.94% 0 / 100   
1 Month -88.79% 0 / 100   
2 Months -92.93% 1 / 100   
6 Months -93.76% 2 / 100   
1 Year -98.02% 2 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog